MedTrace Logo

ExAblate Treatment of Medication Refractory Obsessive Compulsive Disorder

NCT01986296 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2020-04-13

No results posted yet for this study

Summary

The goal of this prospective, non-randomized, single-arm, single site, feasibility study is to develop and collect data to evaluate the safety and initial effectiveness of this treatment using this ExAblate transcranial System in the treatment of Medication-Refractory OCD.

Conditions

  • Medication-refractory Obsessive Compulsive Disorder (OCD)

Interventions

DEVICE

ExAblate Transcranial MRgFUS System

Treatment with the ExAblate Transcranial MRgFUS System.

Sponsors & Collaborators

  • InSightec

    lead INDUSTRY

Principal Investigators

  • Jin Woo Chang, Prof. · Yonsei University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01986296 on ClinicalTrials.gov